Cancer Vaccines Show Promise. But We Have More Work to Do.
(MedPage Today) -- The controversy surrounding the premature disclosure of Moderna and Merck's mRNA melanoma vaccine results risks overshadowing a more consequential clinical discussion: how individualized cancer vaccines might fit into an increasingly...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.